ALPINE GROUP PARTNERS, LLC.

Lobbying for COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 8, 2025

Lobbying activity 2

Health Issues

Issues regarding the reimbursement of radiopharmaceuticals Facilitating Innovative Nuclear Diagnostics Act of 2023

Medicare/Medicaid

Issues regarding the reimbursement of radiopharmaceuticals Facilitating Innovative Nuclear Diagnostics Act of 2023

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.